Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease.
Identifieur interne : 001357 ( PubMed/Curation ); précédent : 001356; suivant : 001358Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease.
Auteurs : Anna Prats París [Espagne] ; Heidi Guerra Saleta ; Maria De La Cruz Crespo Maraver ; Emmanuel Silvestre ; Maite Garolera Freixa ; Cristina Petit Torrellas ; Silvia Alonso Pont ; Marc Fabra Nadal ; Sheila Alcaine Garcia ; Maria Victoria Perea Bartolomé ; Valentina Ladera Fernández ; Angels Rusi Ol BayésSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2011.
English descriptors
- KwdEn :
- MESH :
- methods : Cognitive Therapy.
- psychology : Cognition Disorders, Parkinson Disease.
- therapy : Cognition Disorders, Parkinson Disease.
- Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Quality of Life, Treatment Outcome.
Abstract
The aim of this study was to analyze the efficacy of a cognitive training program on cognitive performance and quality of life in nondemented Parkinson's disease patients. Participants who met UK Brain Bank diagnosis criteria for Parkinson's disease, with I-III Hoehn & Yahr, aged 50-80, and nondemented (Mini-Mental State Examination ≥ 23) were recruited. Patient's cognitive performance and functional and quality-of-life measures were assessed with standardized neuropsychological tests and scales at baseline and after 4 weeks. Subjects were randomly and blindly allocated by age and premorbid intelligence (Vocabulary, Wechsler Adult Intelligence Scale-III) into 2 groups: an experimental group and a control group. The experimental group received 4 weeks of 3 weekly 45-minute sessions using multimedia software and paper-and-pencil cognitive exercises, and the control group received speech therapy. A total of 28 patients were analyzed. Compared with the control group participants (n = 12), the experimental group participants (n = 16) demonstrated improved performance in tests of attention, information processing speed, memory, visuospatial and visuoconstructive abilities, semantic verbal fluency, and executive functions. There were no observable benefits in self-reported quality of life or cognitive difficulties in activities of daily living. We concluded that intensive cognitive training may be a useful tool in the management of cognitive functions in Parkinson's disease. © 2011 Movement Disorder Society.
DOI: 10.1002/mds.23688
PubMed: 21442659
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001357
Links to Exploration step
pubmed:21442659Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease.</title><author><name sortKey="Paris, Anna Prats" sort="Paris, Anna Prats" uniqKey="Paris A" first="Anna Prats" last="París">Anna Prats París</name><affiliation wicri:level="1"><nlm:affiliation>Unitat de Parkinson i Trastorns del Moviment, Centro Médico Teknon. Barcelona, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Unitat de Parkinson i Trastorns del Moviment, Centro Médico Teknon. Barcelona</wicri:regionArea></affiliation></author><author><name sortKey="Saleta, Heidi Guerra" sort="Saleta, Heidi Guerra" uniqKey="Saleta H" first="Heidi Guerra" last="Saleta">Heidi Guerra Saleta</name></author><author><name sortKey="De La Cruz Crespo Maraver, Maria" sort="De La Cruz Crespo Maraver, Maria" uniqKey="De La Cruz Crespo Maraver M" first="Maria" last="De La Cruz Crespo Maraver">Maria De La Cruz Crespo Maraver</name></author><author><name sortKey="Silvestre, Emmanuel" sort="Silvestre, Emmanuel" uniqKey="Silvestre E" first="Emmanuel" last="Silvestre">Emmanuel Silvestre</name></author><author><name sortKey="Freixa, Maite Garolera" sort="Freixa, Maite Garolera" uniqKey="Freixa M" first="Maite Garolera" last="Freixa">Maite Garolera Freixa</name></author><author><name sortKey="Torrellas, Cristina Petit" sort="Torrellas, Cristina Petit" uniqKey="Torrellas C" first="Cristina Petit" last="Torrellas">Cristina Petit Torrellas</name></author><author><name sortKey="Pont, Silvia Alonso" sort="Pont, Silvia Alonso" uniqKey="Pont S" first="Silvia Alonso" last="Pont">Silvia Alonso Pont</name></author><author><name sortKey="Nadal, Marc Fabra" sort="Nadal, Marc Fabra" uniqKey="Nadal M" first="Marc Fabra" last="Nadal">Marc Fabra Nadal</name></author><author><name sortKey="Garcia, Sheila Alcaine" sort="Garcia, Sheila Alcaine" uniqKey="Garcia S" first="Sheila Alcaine" last="Garcia">Sheila Alcaine Garcia</name></author><author><name sortKey="Bartolome, Maria Victoria Perea" sort="Bartolome, Maria Victoria Perea" uniqKey="Bartolome M" first="Maria Victoria Perea" last="Bartolomé">Maria Victoria Perea Bartolomé</name></author><author><name sortKey="Fernandez, Valentina Ladera" sort="Fernandez, Valentina Ladera" uniqKey="Fernandez V" first="Valentina Ladera" last="Fernández">Valentina Ladera Fernández</name></author><author><name sortKey="Bayes, Angels Rusi Ol" sort="Bayes, Angels Rusi Ol" uniqKey="Bayes A" first="Angels Rusi Ol" last="Bayés">Angels Rusi Ol Bayés</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="doi">10.1002/mds.23688</idno><idno type="RBID">pubmed:21442659</idno><idno type="pmid">21442659</idno><idno type="wicri:Area/PubMed/Corpus">001357</idno><idno type="wicri:Area/PubMed/Curation">001357</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease.</title><author><name sortKey="Paris, Anna Prats" sort="Paris, Anna Prats" uniqKey="Paris A" first="Anna Prats" last="París">Anna Prats París</name><affiliation wicri:level="1"><nlm:affiliation>Unitat de Parkinson i Trastorns del Moviment, Centro Médico Teknon. Barcelona, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Unitat de Parkinson i Trastorns del Moviment, Centro Médico Teknon. Barcelona</wicri:regionArea></affiliation></author><author><name sortKey="Saleta, Heidi Guerra" sort="Saleta, Heidi Guerra" uniqKey="Saleta H" first="Heidi Guerra" last="Saleta">Heidi Guerra Saleta</name></author><author><name sortKey="De La Cruz Crespo Maraver, Maria" sort="De La Cruz Crespo Maraver, Maria" uniqKey="De La Cruz Crespo Maraver M" first="Maria" last="De La Cruz Crespo Maraver">Maria De La Cruz Crespo Maraver</name></author><author><name sortKey="Silvestre, Emmanuel" sort="Silvestre, Emmanuel" uniqKey="Silvestre E" first="Emmanuel" last="Silvestre">Emmanuel Silvestre</name></author><author><name sortKey="Freixa, Maite Garolera" sort="Freixa, Maite Garolera" uniqKey="Freixa M" first="Maite Garolera" last="Freixa">Maite Garolera Freixa</name></author><author><name sortKey="Torrellas, Cristina Petit" sort="Torrellas, Cristina Petit" uniqKey="Torrellas C" first="Cristina Petit" last="Torrellas">Cristina Petit Torrellas</name></author><author><name sortKey="Pont, Silvia Alonso" sort="Pont, Silvia Alonso" uniqKey="Pont S" first="Silvia Alonso" last="Pont">Silvia Alonso Pont</name></author><author><name sortKey="Nadal, Marc Fabra" sort="Nadal, Marc Fabra" uniqKey="Nadal M" first="Marc Fabra" last="Nadal">Marc Fabra Nadal</name></author><author><name sortKey="Garcia, Sheila Alcaine" sort="Garcia, Sheila Alcaine" uniqKey="Garcia S" first="Sheila Alcaine" last="Garcia">Sheila Alcaine Garcia</name></author><author><name sortKey="Bartolome, Maria Victoria Perea" sort="Bartolome, Maria Victoria Perea" uniqKey="Bartolome M" first="Maria Victoria Perea" last="Bartolomé">Maria Victoria Perea Bartolomé</name></author><author><name sortKey="Fernandez, Valentina Ladera" sort="Fernandez, Valentina Ladera" uniqKey="Fernandez V" first="Valentina Ladera" last="Fernández">Valentina Ladera Fernández</name></author><author><name sortKey="Bayes, Angels Rusi Ol" sort="Bayes, Angels Rusi Ol" uniqKey="Bayes A" first="Angels Rusi Ol" last="Bayés">Angels Rusi Ol Bayés</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="eISSN">1531-8257</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Cognition Disorders (psychology)</term><term>Cognition Disorders (therapy)</term><term>Cognitive Therapy (methods)</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Neuropsychological Tests</term><term>Parkinson Disease (psychology)</term><term>Parkinson Disease (therapy)</term><term>Quality of Life</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Cognitive Therapy</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Cognition Disorders</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Cognition Disorders</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Neuropsychological Tests</term><term>Quality of Life</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The aim of this study was to analyze the efficacy of a cognitive training program on cognitive performance and quality of life in nondemented Parkinson's disease patients. Participants who met UK Brain Bank diagnosis criteria for Parkinson's disease, with I-III Hoehn & Yahr, aged 50-80, and nondemented (Mini-Mental State Examination ≥ 23) were recruited. Patient's cognitive performance and functional and quality-of-life measures were assessed with standardized neuropsychological tests and scales at baseline and after 4 weeks. Subjects were randomly and blindly allocated by age and premorbid intelligence (Vocabulary, Wechsler Adult Intelligence Scale-III) into 2 groups: an experimental group and a control group. The experimental group received 4 weeks of 3 weekly 45-minute sessions using multimedia software and paper-and-pencil cognitive exercises, and the control group received speech therapy. A total of 28 patients were analyzed. Compared with the control group participants (n = 12), the experimental group participants (n = 16) demonstrated improved performance in tests of attention, information processing speed, memory, visuospatial and visuoconstructive abilities, semantic verbal fluency, and executive functions. There were no observable benefits in self-reported quality of life or cognitive difficulties in activities of daily living. We concluded that intensive cognitive training may be a useful tool in the management of cognitive functions in Parkinson's disease. © 2011 Movement Disorder Society.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">21442659</PMID><DateCreated><Year>2011</Year><Month>06</Month><Day>21</Day></DateCreated><DateCompleted><Year>2011</Year><Month>11</Month><Day>02</Day></DateCompleted><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>7</Issue><PubDate><Year>2011</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Movement disorders : official journal of the Movement Disorder Society</Title><ISOAbbreviation>Mov. Disord.</ISOAbbreviation></Journal><ArticleTitle>Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease.</ArticleTitle><Pagination><MedlinePgn>1251-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.23688</ELocationID><Abstract><AbstractText>The aim of this study was to analyze the efficacy of a cognitive training program on cognitive performance and quality of life in nondemented Parkinson's disease patients. Participants who met UK Brain Bank diagnosis criteria for Parkinson's disease, with I-III Hoehn & Yahr, aged 50-80, and nondemented (Mini-Mental State Examination ≥ 23) were recruited. Patient's cognitive performance and functional and quality-of-life measures were assessed with standardized neuropsychological tests and scales at baseline and after 4 weeks. Subjects were randomly and blindly allocated by age and premorbid intelligence (Vocabulary, Wechsler Adult Intelligence Scale-III) into 2 groups: an experimental group and a control group. The experimental group received 4 weeks of 3 weekly 45-minute sessions using multimedia software and paper-and-pencil cognitive exercises, and the control group received speech therapy. A total of 28 patients were analyzed. Compared with the control group participants (n = 12), the experimental group participants (n = 16) demonstrated improved performance in tests of attention, information processing speed, memory, visuospatial and visuoconstructive abilities, semantic verbal fluency, and executive functions. There were no observable benefits in self-reported quality of life or cognitive difficulties in activities of daily living. We concluded that intensive cognitive training may be a useful tool in the management of cognitive functions in Parkinson's disease. © 2011 Movement Disorder Society.</AbstractText><CopyrightInformation>Copyright © 2011 Movement Disorder Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>París</LastName><ForeName>Anna Prats</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Unitat de Parkinson i Trastorns del Moviment, Centro Médico Teknon. Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saleta</LastName><ForeName>Heidi Guerra</ForeName><Initials>HG</Initials></Author><Author ValidYN="Y"><LastName>de la Cruz Crespo Maraver</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Silvestre</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Freixa</LastName><ForeName>Maite Garolera</ForeName><Initials>MG</Initials></Author><Author ValidYN="Y"><LastName>Torrellas</LastName><ForeName>Cristina Petit</ForeName><Initials>CP</Initials></Author><Author ValidYN="Y"><LastName>Pont</LastName><ForeName>Silvia Alonso</ForeName><Initials>SA</Initials></Author><Author ValidYN="Y"><LastName>Nadal</LastName><ForeName>Marc Fabra</ForeName><Initials>MF</Initials></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Sheila Alcaine</ForeName><Initials>SA</Initials></Author><Author ValidYN="Y"><LastName>Bartolomé</LastName><ForeName>Maria Victoria Perea</ForeName><Initials>MV</Initials></Author><Author ValidYN="Y"><LastName>Fernández</LastName><ForeName>Valentina Ladera</ForeName><Initials>VL</Initials></Author><Author ValidYN="Y"><LastName>Bayés</LastName><ForeName>Angels Rusiñol</ForeName><Initials>AR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>03</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mov Disord</MedlineTA><NlmUniqueID>8610688</NlmUniqueID><ISSNLinking>0885-3185</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D003072">Cognition Disorders</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName><QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D015928">Cognitive Therapy</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D009483">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="Y" UI="D011788">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2011</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="aheadofprint"><Year>2011</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="doi">10.1002/mds.23688</ArticleId><ArticleId IdType="pubmed">21442659</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001357 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001357 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:21442659
|texte= Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:21442659" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |